European Digital HealthTech Conference 2024


Fabienne Roussel

Vesalius Biocapital IV Partners



Dr. Fabienne Roussel is an experienced healthcare specialist with more than 20 years of experience in managing innovation in life sciences. She joins Vesalius Biocapital IV as Partner, having served as an Analyst for VBC III. Prior to this, she held Technology Transfer positions at several research institutions in Belgium and Luxembourg, where she designed the innovation management strategy, managed the institutional intellectual property portfolios, and accompanied spin-off company creation. She gained her professional recognition through the title of Registered Technology Transfer Professional. This experience came on the heel of a specialization as Patent Agent in the US, first in a reputable law firm (Arnold, White & Durkee, LLP, now Winston & Strawn) and then a biotech company (Human Genome Sciences, acquired by GlaxoSmithKline in 2012).

This speaker will participate in the following sessions